Articles dans des revues avec comité de lecture (6)
  1. 1. El Oumeiri, B. G., Dewachter, L., Van De Borne, P., Hubesch, G., Melot, C., Jespers, P., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2023). Altered Left Ventricular Rat Gene Expression Induced by the Myosin Activator Omecamtiv Mecarbil. Genes, 14(1). doi:10.3390/genes14010122
  2. 2. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Jespers, P., Dewachter, L., Stefanidis, C., McEntee, K., & Vanden Eynden, F. (2022). Detection of soluble suppression of tumorigenicity 2 and N-terminal B-type natriuretic peptide in a rat model of aortic regurgitation: differential responses to omecamtiv mecarbil. Journal of basic & clinical physiology & pharmacology, 33(6), 743-750. doi:10.1515/jbcpp-2022-0215
  3. 3. Garcia, B., Su, F., Dewachter, L., Favory, R., Khaldi, A., Moiroux-Sahraoui, A., Annoni, F., Vasques-Nóvoa, F., Rocha-Oliveira, E., Roncon-Albuquerque, R., Hubesch, G., Njimi, H., Vincent, J. L., Taccone, F., Creteur, J., & Herpain, A. (2022). Myocardial effects of angiotensin II compared to norepinephrine in an animal model of septic shock. Critical care, 26(1), 281. doi:10.1186/s13054-022-04161-3
  4. 4. Hubesch, G., Hanthazi, A., Acheampong, A., Chomette, L., Lasolle, H., Hupkens, E., Jespers, P., Vegh, G., Watu Malu Wembonyama, C., Verhoeven, C., Dewachter, C., Vachiery, J.-L., McEntee, K., & Dewachter, L. (2022). A Preclinical Rat Model of Heart Failure With Preserved Ejection Fraction With Multiple Comorbidities. Frontiers in Cardiovascular Medicine, 8. doi:10.3389/fcvm.2021.809885
  5. 5. El Oumeiri, B. G., Van De Borne, P., Hubesch, G., Herpain, A., Annoni, F., Jespers, P., Stefanidis, C., Mc Entee, K., & Vanden Eynden, F. (2021). The myosin activator omecamtiv mecarbil improves wall stress in a rat model of chronic aortic regurgitation. Physiological Reports, 9(16), e14988. doi:10.14814/phy2.14988
  6. 6. Hanthazi, A., Jespers, P., Vegh, G., Dubois, C., Hubesch, G., Springael, J.-Y., Dewachter, L., & McEntee, K. (2020). Chemerin Added to Endothelin-1 Promotes Rat Pulmonary Artery Smooth Muscle Cell Proliferation and Migration. Frontiers in physiology, 11, 926. doi:10.3389/fphys.2020.00926
    7.   Participations à des congrès et colloques internationaux (7)
  7. 1. Hubesch, G. (2021). Obesity-prone rats fed with high fat diet as a model of HFpEF. Paper session presented at Belgian Working Group Basic Research in Cardiology (BWGBRC) (2021-06-09).
  8. 2. Hubesch, G., Hanthazi, A., Acheampong, A., Watu Malu Wembonyama, C., Hupkens, E., Jespers, P., Vegh, G., McEntee, K., & Dewachter, L. (2021). Obesity-prone rats fed with high fat diet as a model of HFpEF. Poster présenté à la conférence Belgian Working Group Basic Research in Cardiology (BWGBRC) (2021-06-09: Belgium).
  9. 3. Hubesch, G., Hanthazi, A., Acheampong, A., Watu Malu Wembonyama, C., Hupkens, E., Jespers, P., Vegh, G., McEntee, K., & Dewachter, L. (2021). Obese prone rats fed with high fat diet as a model of HFpEF. Poster présenté à la conférence Belgian Society of Cardiology (40: 2021-02-11: Brussels, Belgium).
  10. 4. Hubesch, G., Hanthazi, A., Acheampong, A., Watu Malu Wembonyama, C., Jespers, P., Vegh, G., Verhoeven, C., Dewachter, L., & McEntee, K. (2019). Respective roles of genetic background and high fat diet in a rodent model of metabolic syndrome. Poster présenté à la conférence Printemps de la Cardiologie (Avril 2019: Lille, France).
  11. 5. Hanthazi, A., Jespers, P., Vegh, G., Hubesch, G., Springael, J.-Y., Dewachter, L., & McEntee, K. (2019). Chemerin/CMKLR1 axis influences pulmonary arterial pressure and the NO signaling pathway. Poster présenté à la conférence Printemps de la Cardiologie (Avril 2019: Lille, France).
  12. 6. Hubesch, G., Hanthazi, A., Hupkens, E., Jespers, P., Vegh, G., Dewachter, L., & McEntee, K. (2018). Effects of obesity on vasoreactivity of the pulmonary and systemic circulation in the rat. Paper session presented at Belgian Working Group of Basic Research in Cardiology (16/11/2018: Louvain-la-Neuve).
    13. << Précédent 1 2 Suivant >>